Red Flag Laws Prevent Suicides
By Lori Solomon HealthDay Reporter
WEDNESDAY, Aug. 28, 2024 -- Extreme risk protection orders (ERPOs) can be an effective suicide prevention tool, according to a study published online Aug. 20 in the Journal of the American Academy of Psychiatry and the Law.
Jeffrey W. Swanson, Ph.D., from the Duke University School of Medicine in Durham, North Carolina, and colleagues assessed the effectiveness of ERPO laws. The analysis included records from 4,583 ERPO respondents in California, Connecticut, Maryland, and Washington.
The researchers found that two evidence-based approaches yielded estimates of 17 and 23 ERPOs needed to prevent one suicide. Among a subset of 2,850 ERPO respondents with documented suicide concern, corresponding estimates were 13 and 18 to prevent one suicide.
"Even if we reduce many of the things that motivate people to injurious behavior, we still live in a society where people have easy access to technology designed to kill efficiently," Swanson said in a statement. "Addressing access to firearms for people who are at risk of harming themselves or others is an evidence-based approach that can save lives."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.